title: Camphene, a plant-derived monoterpene, reduces plasma cholesterol and triglycerides in hyperlipidemic rats independently of HMG-CoA reductase activity.
abstract: BACKGROUND
  Central to the pathology of coronary heart disease is the accumulation of lipids, cholesterol and triglycerides, within the intima of arterial blood vessels. The search for drugs to treat dislipidemia, remains a major pharmaceutical focus. In this study, we evaluated the hypolipidemic properties of the essential oil from Chios mastic gum (MGO).
  
  
  RESULTS
  The hypolipidemic effect of MGO was investigated in naïve as well as in rats susceptible to detergent-induced hyperlipidemia. Serum cholesterol and triglycerides were determined using commercial kits. HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase activity was measured in HepG2 cell extracts using a radioactive assay; cellular cholesterol and cholesterol esters were assessed using gas chromatography. MGO administration into naïve rats resulted in a dose-dependent reduction in the constitutive synthesis of serum cholesterol and triglycerides. In hyperlipidemic rats, MGO treatment had also a strong hypolipidemic effect. By testing various components of MGO, we show for the first time that the hypolipidemic action is associated with camphene. Administration of camphene at a dose of 30 µg/gr of body weight in hyperlipidemic rats resulted in a 54.5% reduction of total cholesterol (p<0.001), 54% of Low Density Lipoprotein (LDL)-cholesterol (p<0.001) and 34.5% of triglycerides (p<0.001). Treatment of HepG2 cells with camphene led to a decrease in cellular cholesterol content to the same extend as mevinolin, a known HMG-CoA reductase inhibitor. The hypolipidemic action of camphene is independent of HMG-CoA reductase activity, suggesting that its hypocholesterolemic and hypotriglyceridemic effects are associated with a mechanism of action different than that of statins.
  
  
  CONCLUSIONS
  Given the critical role that the control of hyperlipidemia plays in cardiovascular disease, the results of our study provide insights into the use of camphene as an alternative lipid lowering agent and merits further evaluation.
authors.affiliation: Department of Genetics, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
authors.forename: Ioanna
authors.initials: I
authors.lastname: Vallianou
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Peroulis
authors.forename: Panayotis
authors.initials: P
authors.lastname: Pantazis
authors.forename: Margarita
authors.initials: M
authors.lastname: Hadzopoulou-Cladaras
mesh_terms: D000214:Acyl Coenzyme A / Q000378:metabolism*; D000818:Animals; D000081008:Bicyclic Monoterpenes; D002460:Cell Line; D002784:Cholesterol / Q000097:blood*; D002849:Chromatography, Gas; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D051381:Rats; D011916:Rats, Inbred F344; D013729:Terpenes / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood*
chemical_list: D000214:Acyl Coenzyme A; D000081008:Bicyclic Monoterpenes; D000960:Hypolipidemic Agents; D013729:Terpenes; D014280:Triglycerides; C008047:3-hydroxy-3-methylglutaryl-coenzyme A; D002784:Cholesterol; C019286:camphene
references.citation: Circulation. 2002 Dec 17;106(25):3143-421
references.pmid: 12485966
references.citation: Control Clin Trials. 1987 Dec;8(4):356-87
references.pmid: 3327654
references.citation: J Chemother. 2001 Dec;13(6):611-4
references.pmid: 11806621
references.citation: Food Chem Toxicol. 2007 Mar;45(3):494-501
references.pmid: 17092621
references.citation: Toxicol In Vitro. 2009 Mar;23(2):295-301
references.pmid: 19135518
references.citation: Fitoterapia. 2003 Feb;74(1-2):170-6
references.pmid: 12628418
references.citation: Atherosclerosis. 1978 May;30(1):45-56
references.pmid: 209796
references.citation: Nutr Cancer. 2006;55(1):86-93
references.pmid: 16965245
references.citation: BMC Med Genomics. 2009 Dec 15;2:68
references.pmid: 20003503
references.citation: Clin Exp Pharmacol Physiol. 1984 Sep-Oct;11(5):541-4
references.pmid: 6395994
references.citation: Pharmacol Ther. 2010 Jun;126(3):263-78
references.pmid: 20227438
references.citation: J Ethnopharmacol. 2010 Feb 3;127(2):205-9
references.pmid: 19961914
references.citation: N Engl J Med. 1998 Dec 24;339(26):1946
references.pmid: 9874617
references.citation: Phytomedicine. 2010 Mar;17(3-4):296-9
references.pmid: 19879118
references.citation: J Ethnopharmacol. 1986 Mar;15(3):271-8
references.pmid: 3724207
references.citation: West J Med. 1978 Jan;128(1):13-25
references.pmid: 204111
references.citation: Can J Biochem Physiol. 1959 Aug;37(8):911-7
references.pmid: 13671378
references.citation: Am J Cardiol. 2005 Jul 4;96(1A):3D-9D
references.pmid: 15992509
references.citation: Biochem Pharmacol. 1980 Aug 1;29(15):2125-7
references.pmid: 7406925
references.citation: Nat Prod Commun. 2010 Feb;5(2):279-82
references.pmid: 20334144
references.citation: Planta Med. 1999 Dec;65(8):749-52
references.pmid: 10630120
references.citation: J Ethnopharmacol. 2002 Nov;83(1-2):135-8
references.pmid: 12413719
references.citation: J Nutr. 1974 Feb;104(2):223-6
references.pmid: 4204246
references.citation: JAMA. 1999 Dec 22-29;282(24):2340-6
references.pmid: 10612322
references.citation: Atherosclerosis. 1987 Nov;68(1-2):59-66
references.pmid: 3500729
references.citation: Nat Rev Drug Discov. 2003 Jul;2(7):517-26
references.pmid: 12815379
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Exp Mol Pathol. 2002 Oct;73(2):135-8
references.pmid: 12231215
references.citation: JAMA. 1972 Aug 14;221(7):661-6
references.pmid: 4261853
references.citation: J Ethnopharmacol. 2007 Apr 20;111(1):43-9
references.pmid: 17150319
references.citation: In Vivo. 2009 Jan-Feb;23(1):63-8
references.pmid: 19368126
references.citation: Phytomedicine. 2007 Apr;14(4):263-72
references.pmid: 16713222
references.citation: Acta Pharmacol Sin. 2007 Apr;28(4):567-72
references.pmid: 17376297
references.citation: Am J Cardiol. 2005 Jul 4;96(1A):47D-50D
references.pmid: 15992516
references.citation: Curr Drug Targets. 2011 Mar 1;12(3):302-21
references.pmid: 20955150
references.citation: Exp Biol Med (Maywood). 2009 May;234(5):553-61
references.pmid: 19234052
references.citation: Atherosclerosis. 2005 Sep;182(1):29-36
references.pmid: 16115472
references.citation: Acta Pharmacol Sin. 2007 Mar;28(3):446-52
references.pmid: 17303010
references.citation: Nat Prod Commun. 2010 Sep;5(9):1421-6
references.pmid: 20923001
references.citation: In Vivo. 2009 Jul-Aug;23(4):583-9
references.pmid: 19567394
references.citation: J Am Coll Cardiol. 2000 Jan;35(1):1-10
references.pmid: 10636252
references.citation: J Dent. 2008 Jul;36(7):535-9
references.pmid: 18468761
references.citation: J Nutr Biochem. 2002 Jan;13(1):55-63
references.pmid: 11834220
references.citation: J Pharmacol Exp Ther. 1989 Feb;248(2):498-505
references.pmid: 2918466
references.citation: J Pharm Pharmacol. 1998 Nov;50(11):1233-9
references.pmid: 9877308
references.citation: World J Gastroenterol. 2007 Feb 7;13(5):748-53
references.pmid: 17278198
references.citation: Analyst. 2000 Sep;125(9):1583-5
references.pmid: 11064938
references.citation: Eur Rev Med Pharmacol Sci. 2010 Sep;14(9):765-9
references.pmid: 21061835
references.citation: J Biol Chem. 1974 Nov 25;249(22):7306-14
references.pmid: 4436312
references.citation: Am J Clin Nutr. 1977 Jun;30(6):985-92
references.pmid: 326023
references.citation: J Exp Med. 1951 Apr 1;93(4):373-84
references.pmid: 14824409
references.citation: Atherosclerosis. 2004 Jun;174(2):293-303
references.pmid: 15136059
references.citation: Cancer. 2006 Jun 15;106(12):2547-55
references.pmid: 16691616
references.citation: Toxicol Appl Pharmacol. 1995 Mar;131(1):163-74
references.pmid: 7878672
references.citation: Angle Orthod. 2007 Jan;77(1):124-8
references.pmid: 17029554
references.citation: World J Gastroenterol. 2007 Dec 7;13(45):6031-6
references.pmid: 18023095
references.citation: Enzyme. 1980;25(2):81-6
references.pmid: 7379775
references.citation: J Biol Chem. 1990 Dec 25;265(36):22474-9
references.pmid: 2176219
references.citation: Am J Respir Cell Mol Biol. 2011 Jul;45(1):95-100
references.pmid: 20855649
references.citation: Expert Opin Pharmacother. 2003 Nov;4(11):1901-38
references.pmid: 14596646
references.citation: Nat Prod Commun. 2009 Dec;4(12):1685-90
references.pmid: 20120107
references.citation: Sci Pharm. 2010;78(3):483-92
references.pmid: 21179360
references.citation: Am J Cardiol. 2005 Jul 4;96(1A):15D-22D
references.pmid: 15992511
references.citation: Adv Enzyme Regul. 1989;28:53-64
references.pmid: 2696346
references.citation: Am J Cardiol. 1987 Oct 30;60(12):33G-42G
references.pmid: 3314447
references.citation: J Ethnopharmacol. 2004 Apr;91(2-3):231-5
references.pmid: 15120444
references.citation: Phytother Res. 2003 May;17(5):501-7
references.pmid: 12748987
references.citation: Curr Opin Lipidol. 2007 Aug;18(4):401-8
references.pmid: 17620856
references.citation: Nutr Cancer. 2009;61(5):640-8
references.pmid: 19838938
references.citation: Biochim Biophys Acta. 1980 Oct 6;620(1):111-9
references.pmid: 7417475
references.citation: J Agric Food Chem. 2005 Oct 5;53(20):7681-5
references.pmid: 16190616
references.citation: Antimicrob Agents Chemother. 2007 Feb;51(2):551-9
references.pmid: 17116667
references.citation: Curr Vasc Pharmacol. 2003 Mar;1(1):11-7
references.pmid: 15320848
references.citation: Lipids. 1972 Jan;7(1):68-74
references.pmid: 5013174
references.citation: J Periodontol. 2003 Apr;74(4):501-5
references.pmid: 12747455
references.citation: Nat Prod Commun. 2009 Jun;4(6):845-8
references.pmid: 19634334
references.citation: J Lipid Res. 1992 Nov;33(11):1569-82
references.pmid: 1464741
references.citation: In Vivo. 2005 Jan-Feb;19(1):93-102
references.pmid: 15796160
references.citation: In Vivo. 2009 Mar-Apr;23(2):215-23
references.pmid: 19414406